This was further supported by a case study of a WD patient with a 379-bp homozygous variant (chr12.52, 586, 149T>C) in the ATP7B promoter, which disrupts MTF1 binding and results in the WD phenotype [182]. This evidence concerns the gene MTF1 and Wilson disease.